Skip to main content
Mabion S.A. logo

Mabion S.A. — Investor Relations & Filings

Ticker · MAB ISIN · PLMBION00016 LEI · 259400KG5JVQPPZL6X53 WAR Manufacturing
Open in API
Filings indexed 1,002 across all filing types
Latest filing 2021-05-20 Interim / Quarterly Rep…
Country PL Poland
Listing WAR MAB

About Mabion S.A.

https://www.mabion.eu/en/

Mabion S.A. is an integrated Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for the development and manufacturing of protein-based biotherapeutics. The company specializes in monoclonal antibodies and biosimilars, offering a complete workflow from cell line development and banking to process optimization and large-scale GMP manufacturing. Core competencies include upstream processing using mammalian cell cultures, downstream purification involving chromatography and viral clearance, and technology transfer for scale-up. Mabion partners with pharmaceutical and biotechnology companies to support both clinical and commercial supply, streamlining the path from gene to final drug product.

Recent filings

Filing Released Lang Actions
Mabion_MSSF 2021_Q1
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial report ('Śródroczne Skrócone Sprawozdanie Finansowe') for Mabion S.A. covering the 3-month period ending March 31, 2021. It contains detailed financial statements, including the statement of comprehensive income, statement of financial position, and statement of cash flows. It is not an announcement of a report, but the report itself, and it contains substantive financial data, fitting the definition of an Interim/Quarterly Report. Q1 2021
2021-05-20 Polish
Zmiany w składzie Zarządu i Rady Nadzorczej Spółki - Content (PL)
Board/Management Information Classification · 99% confidence The document text explicitly details significant changes in the company's management structure: the resignation of the Chairman of the Supervisory Board, the appointment of a new CEO (Krzysztof Kaczmarczyk), the dismissal of the previous CEO (Dirk Kreder), and the appointment of a new Chairman of the Supervisory Board (Robert Koński). It also outlines the new division of responsibilities among the management board members. This content directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2021-05-14 Polish
Zmiany w składzie Zarządu i Rady Nadzorczej Spółki - korekta numeracji raportu bieżącego z dnia 13 maja 2021 roku - Content (PL)
Report Publication Announcement Classification · 99% confidence The document is a very short announcement (516 characters) from the Management Board ('Zarząd') of Mabion S.A. It explicitly states that a previous current report ('raport bieżący') was incorrectly numbered and this document serves to correct the numbering (from 35/2021 to 36/2021). This is a notification about a procedural correction to a prior regulatory filing. Since it is a brief announcement regarding a filing correction rather than the full content of a specific report type (like ER, IR, or 10-K), and it doesn't fit the specific categories like Director's Dealing (DIRS) or Management Change (MANG) directly, it falls best under the general regulatory announcement category, RNS, as a miscellaneous regulatory filing correction.
2021-05-14 Polish
Sprawozdanie Zarządu
Management Reports Classification · 95% confidence The document is titled 'Sprawozdanie Zarządu z działalności Mabion S.A. za rok 2020' (Management Board Report on the activities of Mabion S.A. for the year 2020). It contains a detailed table of contents covering organizational structure, business activities, financial analysis, development perspectives, corporate governance, and shareholder information. This is a comprehensive management report (Management Discussion and Analysis) that accompanies the annual financial statements. In the context of the provided categories, this aligns with the 'Management Reports' (MDA) classification, as it provides the management's detailed explanation of financial results, business trends, and outlook for the fiscal year. FY 2020
2021-04-30 Polish
Sprawozdanie finansowe
Annual Report Classification · 100% confidence The document is a comprehensive financial report for Mabion S.A. for the fiscal year ending December 31, 2020. It contains detailed financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, Statement of Cash Flows, and Statement of Changes in Equity, along with supplementary notes. Since it covers a full fiscal year and provides substantive financial data, it is classified as an Annual Report (10-K equivalent for non-US entities). FY 2020
2021-04-30 Polish
Sprawozdanie z badania rocznego sprawozdania finansowego
Audit Report / Information Classification · 99% confidence The document is titled "Sprawozdanie niezależnego biegłego rewidenta z badania" (Independent Auditor's Report on the Audit) and specifically mentions "Sprawozdanie z badania rocznego sprawozdania finansowego" (Report on the audit of the annual financial statements) for the year ended December 31, 2020. It contains the auditor's opinion, basis for opinion, scope of the audit, and details key audit matters, which are definitive characteristics of an Audit Report. Although it relates to the annual financial statements, the document itself is the formal opinion issued by the external auditor, which aligns best with the 'Audit Report / Information' category (AR), rather than the 'Annual Report' (10-K) which is the primary financial filing prepared by the company management. FY 2020
2021-04-30 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.